Home » NantHealth Launches Genomic Proteomic Spectrometry Cancer Molecular Test
NantHealth Launches Genomic Proteomic Spectrometry Cancer Molecular Test
June 6, 2016
NantHealth has launched its Genomic Proteomic Spectrometry Cancer molecular test that measures the proteins in a patient’s tumor tissue.
The diagnostic features targeted quantitative proteomics with DNA and RNA sequencing, as well as a knowledge database with hundreds of oncogenes.
Results are available to physicians within 21 days in a report or through the GPS Cancer Genome Browser mobile application. — Michael Cipriano
Upcoming Events
-
21Oct